Eli Lilly offers discounted Zepbound vials at half the usual monthly cost
Eli Lilly offers discounted Zepbound vials at half the usual monthly cost - CBS News
Tag: Lilly
Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vials
Drugmaker Eli Lilly said Tuesday it will sell single-use vials of its weight-loss drug Zepbound at a fraction of the ...
FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly
The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for the third ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most ...
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan ...
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. Mike Blake ...
Eli Lilly teams with Amazon to offer home delivery of its Zepbound weight-loss drug
Four months after Eli Lilly obtained regulatory approval to sell its diabetes medication under a different name for weight loss, ...
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021. Smith Collection | Gado ...
FDA approves a new weight loss drug, Zepbound from Eli Lilly
The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which ...
Eli Lilly expects FDA decision on Alzheimer’s treatment donanemab by the end of the year
Eli Lilly on Monday said it applied for full U.S. Food and Drug Administration approval of its Alzheimer's treatment, donanemab, ...
